Tokyo, Sept. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063016) titled 'Relationship Between Physiological Mirror Activity and Corticomuscular Coh... Read More
Tokyo, Sept. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063015) titled 'The Relationship Between Temporal and Spatial Estimation Errors and the Di... Read More
Tokyo, Sept. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063009) titled 'Effects of Brief Postprandial Exercise Involving Large Lower-Limb Muscle G... Read More
Tokyo, Sept. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062965) titled 'Evaluation of the efficacy of 8-week continuous intake of the study food o... Read More
Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating... Read More
Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating... Read More
Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pl... Read More
Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solu... Read More
Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib ... Read More
Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pemb... Read More